These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 14429778)
21. [The prospects of use of chelating agents in internal medicine, surgery and orthopedics]. BERNEAGA A Wien Klin Wochenschr; 1959 Dec; 71():992-5. PubMed ID: 13799730 [No Abstract] [Full Text] [Related]
22. Use of the chelating agent edathamil disodium in acrosclerosis, sarcoidosis and other skin conditions with comments on tryptophan metabolism in sarcoidosis. JOHNSON SA Wis Med J; 1960 Oct; 59():651-5. PubMed ID: 13790343 [No Abstract] [Full Text] [Related]
23. Porphyria; its manifestations and treatment with chelating agents. PAINTER JT; MORROW EJ Tex State J Med; 1959 Oct; 55():811-8. PubMed ID: 14429835 [No Abstract] [Full Text] [Related]
24. [Progressive scleroderma with considerable electromyographical changes treated with chelating agents (E.D.T.A.)]. da FONSECA J Med (Oporto); 1960 Feb; 41():469-76. PubMed ID: 13823810 [No Abstract] [Full Text] [Related]
25. [Recent advance in the therapy of metal poisoning with complexing agents]. Aaseth J Tidsskr Nor Laegeforen; 1972 May; 12(13):918-22. PubMed ID: 4624035 [No Abstract] [Full Text] [Related]
26. [Observations on oral treatment with chelating agents in workers employed in the production of tetraethyl lead]. PEDINELLI M; STRINGARI M Rass Med Ind Ig Lav; 1959; 28():514-25. PubMed ID: 14431336 [No Abstract] [Full Text] [Related]
27. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury. George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232 [TBL] [Abstract][Full Text] [Related]
28. [Action of chelating drugs in porphyria. (Critical review of the literature and personal experience)]. PANCONESI E; GIANNOTTI B Rass Dermatol Sifilogr; 1962; 15():8-32. PubMed ID: 14483496 [No Abstract] [Full Text] [Related]
29. Chelation in clinical otosclerosis. STECKER RH; BENNETT M AMA Arch Otolaryngol; 1959 Nov; 70():627-9. PubMed ID: 13833954 [No Abstract] [Full Text] [Related]
30. [Treatment by chelators of salivary lithiasis]. AUBRY M; SARFATI W Ann Otolaryngol; 1959; 76():971-2. PubMed ID: 13795033 [No Abstract] [Full Text] [Related]
31. [On the influence of chelating agents on the excretion and the behavior of mercury in acute mercury poisoning]. Eybl V; Sýkora J; Mertl F Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Nov; 252(1):79-84. PubMed ID: 4222871 [No Abstract] [Full Text] [Related]
32. [Chelation by E.D.T.A. (ethylenediaminetetraacetic acid) in rheumatology: therapeutic induction of flexibility and detoxication]. THIERS H; COLOMB D; FAYOLLE J Lyon Med; 1959 Aug; 91():339-44. PubMed ID: 13837811 [No Abstract] [Full Text] [Related]
33. Glomerular perfusion during acute renal insufficiency from mercury poisoning in the rat. SIMS EA; GOLDBERG HI; KELLY JR; SISCO B J Lab Clin Med; 1959 Sep; 54():440-9. PubMed ID: 14447029 [No Abstract] [Full Text] [Related]
34. [Is the prevention of lead poisoning with calcium edathamil possible?]. POTT R Arch Gewerbepathol Gewerbehyg; 1959; 17():354-64. PubMed ID: 14434464 [No Abstract] [Full Text] [Related]
35. [1st therapeutic trials of "chelating agents" (EDTA) in cases of scleroderma and of other fibrosclerotic processes of the dermal connective tissues]. AGOSTINI A; ZANCA A G Ital Dermatol; 1961; 102():85-106. PubMed ID: 13859615 [No Abstract] [Full Text] [Related]
36. [Mercury poisoning]. BORBELY F Z Unfallmed Berufskr; 1960 Mar; 53():31-53. PubMed ID: 13802705 [No Abstract] [Full Text] [Related]